Drugs / Autologous Adipose Tissue-Derived Mesenchymal Stem Cell
Autologous Adipose Tissue-Derived Mesenchymal Stem Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05783154 | Sep 2022 → Jul 2024 | osteoarthritis, knee | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Adipose Tissue-Derived Mesenchymal Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05783154 ↗ |
| Modality | Cell therapy | “Mesenchymal stem cells (MSCs) therapies for knee osteoarthritis are being investigated in various corners of the world.” NCT05783154 ↗ |